Notes / Company

Viyash Scientific Ltd.

VIYASH BSE 512529 ISIN INE807F01027 Pharmaceuticals

Fundamentals

Market cap: ₹10,747 cr
P/E: 141.65×
ROE: 3.11%
Debt / equity: 0.63
52-week range: 166.20 — 269.00

Research on Tijori Finance

The timeline — 1 note on Viyash Scientific Ltd.

May 2026

21 May 26 · 08:15 IST Brief

Brief · Concalls

Viyash Scientific targets ₹1,000 cr EBITDA in 2-3 years, pivots to companion animals

Management's May concall reaffirms synergy-led margin expansion and sets an FY27 EBITDA run rate of ~₹800 crore.

Verify on exchange BSE filings for VIYASH NSE filings for VIYASH Tijori Finance company page